According to AquaBounty's latest financial reports the company has a price-to-book ratio of 0.0444.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.0633 | -77.64% |
2022-12-31 | 0.2831 | -59.42% |
2021-12-31 | 0.6976 | -83.49% |
2020-12-31 | 4.23 | 113.87% |
2019-12-31 | 1.98 | 48.32% |
2018-12-31 | 1.33 | -23.5% |
2017-12-31 | 1.74 | |
2016-12-31 | N/A | |
2015-12-31 | N/A | |
2014-12-31 | N/A | |
2013-12-31 | N/A | |
2012-12-31 | N/A | |
2011-12-31 | N/A | |
2010-12-31 | N/A | |
2009-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Organovo ONVO | 1.92 | 4,230.78% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 4.74 | 10,566.56% | ๐ฌ๐ง UK |
Novavax NVAX | -2.96 | -6,763.31% | ๐บ๐ธ USA |
Novocure
NVCR | 6.64 | 14,852.16% | Jersey |